Skip to main content
Clinical Trials/DRKS00020118
DRKS00020118
Completed
未知

A Before-After Study investigating the effect of an intervention aiming to increase vaccination rates for Hepatitis B, Streptococcus pneumoniae and Herpes Zoster of oncological Patients under Treatment - The Easy Vaccination in Oncology (EVO) Study - EVO

Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin0 sites519 target enrollmentFebruary 18, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
C80
Sponsor
Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin
Enrollment
519
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2021
End Date
January 31, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vivantes Klinikum Neukölln - Hämatologie, Onkologie und Palliativmedizin

Eligibility Criteria

Inclusion Criteria

  • Written informed consent
  • \- Age \>/\= 18 years
  • \- Established cancer diagnosis
  • \- Baseline: Under anti\-neoplastic treatment
  • \- Follow\-up: Under anti\-neoplastic treatment with at least one doctor appointment at study side at least 4 weeks before
  • \- Intervention: Planned or under anti\-neoplastic treatment

Exclusion Criteria

  • \- Patients who are unable to consent
  • \- Known intolerance towards planned vaccinations
  • \- B\- and T\-cell depleting treatment

Outcomes

Primary Outcomes

Not specified

Similar Trials